鉴定了miR-192-5p的新型肝基因

Yoshifumi Saito1, Akari Obayashi1, Riho Ichikawa1

  • 1Division of Molecular Science, Laboratory of Metabolism, Graduate School of Science and Technology, Gunma University, Gunma, Japan.

概括

微RNA-192-5p通过抑制新型向基因,作为肝细胞癌 (HCC) 的瘤抑制剂,为这种致命的癌症提供了潜在的新疗法策略.